Approach: Reducing the likelihood is focused on:
Demonstrating in-space monitoring capabilities, outlining necessary training, developing medical system requirements, and providing examples of representative technology solutions (e.g. Autonomous Medical Officer Support software technology demonstration)
Incorporating renal stone computational models into trade space analysis tools for the purpose of developing integrated exploration medical system models
Considering of known or novel pharmaceutical countermeasures for inclusion in exploration candidate formulary (please refer to pharm risk for more information)
Reducing the consequence is focused on:
Defining conservative renal stone management capabilities, outlining necessary training, and incorporating capabilities into exploration medical system models
Completing the in-process “renal stone management technology development and clinical validation study”
Develop ultrasound imaging protocols to enhance kidney stone detection in space.
Manipulate existing elastic wave and bubble dynamic models to aid in refining kidney stone detection protocols.
Determine how hypobaric and hyperbaric conditions alter the TA.
Determine how urine pH and stone type affect the TA.
Determine how exposure to gas concentrations unique to the space travel vehicles alters the TA.
The deliverable is a TRL 7 ultrasound system for the imaging and detection of kidney stones. The TRL 7 delivery will contribute to the closure of Gap Med12.